Shares of Altimmune (NASDAQ:ALT) rallied 30% in afternoon trading after the company issued several business updates along ...
Michael Lasser, UBS retail analyst, joins 'Squawk on the Street' to discuss if warm weather impacted Home Depot's quarterly ...
UBS Global Wealth Management has cut its forecast for Chinese equities due to rising concerns over potential US tariffs and a ...
UBS analyst Eliana Merle initiated coverage of Altimmune (ALT) with a Buy rating and $26 price target The firm sees Altimmune as “highly ...
Gold prices fell by 3% following the confirmation that Donald Trump had won the U.S. presidential election, but prices have ...
In this piece, we will take a look at the top stocks with improving earnings revisions, P/E ratios, EPS growth, and other ...
UBS Group AG expects rich Australians to seek more investment outside the country as assets grow and they want to diversify ...
UBS raised the firm’s price target on Nvidia (NVDA) to $185 from $150 and keeps a Buy rating on the shares. The firm remains bullish on ...
Swiss bank UBS said on Thursday it had successfully piloted a blockchain-based payment system it has developed to improve ...
Thiago Batista assume o comando do departamento de equity research para Brasil no UBS BB Investment Bank, supervisionando a ...
Dalata Hotel (GB:DAL) has released an update. UBS Group AG has increased its financial instruments holdings in Dalata Hotel ...
Sergio Ermotti’s integration of Credit Suisse is clearly going well. The only real question is why so few of the touted cost ...